Lipid-based Nutrient Supplement Small Quantity (LNS-SQ)
20 g individual sachet
✓ Prevents stunting
✓ Improves the children's growth, their motor and cognitive development
For children 6 to 24 months of age
1 sachet / day / child
→ This product fits home fortification programs
Enov'Nutributter®+ is a Lipid-based Nutrient Supplement Small Quantity (LNS-SQ)
✓ For children from 6 to 24 months
Enov’Nutributter®+ has been developed in collaboration with researchers from the iLiNS Project operating in Ghana, Malawi, and Burkina Faso to prevent deficiencies of infants whose diet may provide energy but lacks varied and nutritious food, and to promote linear growth and motor development of the infants.
Ideally, babies should be exclusively breastfed up to the age of 6 months. After this, mother's milk no longer provides all the energy and nutrients the infant needs to grow. A high-quality food supplement then becomes indispensable to compensate for this deficit, but this is sometimes unavailable or inaccessible in many developing countries.
Originally developed for children aged between 6 and 12 months at risk of malnutrition, Enov'Nutributter®+ is now also used as an addition to continued breastfeeding (up to 24 months) and supplementary foods.
Enov'Nutributter®+ is reserved for use with young children and must not be shared with the other members of the family, as its micronutrient content is especially calculated to meet the needs of a child.
✓ For the prevention of malnutrition
Enov'Nutributter®+ is intended to fortify the food supplements of young children and to aid in their motor and cognitive development.
Daily consumption of Enov'Nutributter®+ over a period of at least four months helps to compensate for any deficiencies in the supplementary food. It provides all the micronutrients (minerals and vitamins) required for growth in children of that age group. Enov'Nutributter®+ is also recommended as a fortifier for feeding children aged between 12 and 24 months, a key period for growth and intellectual development.
All nutritional studies highlight the first 1000 days of life, from conception to two years, as crucial for the development of a child.
In areas where malaria is endemic, it is recommended to divide the consumption of the product into two, to avoid the risks associated with the iron supplement contained in Enov Nutributter®+.
Enov'Nutributter®+ is not a substitute for a varied and nutritious diet, nor breastfeeding.
Immediate breastfeeding after birth, exclusive during the first 6 months and recommended for at least 24 months.
Key evidences of acceptability:
- Well accepted by children in Ghana , Guatemala, Bangladesh, Malawi
Key evidences of efficacy:
- Burkina Faso:
- Providing Enov’Nutributter®+ daily along with malaria and diarrhea treatment, significantly increased growth and reduced stunting, wasting and anemia prevalence in young children
- The impact of providing LNS-SQ with varied amounts of zinc, along with illness treatment, on zinc-related outcomes was compared with standard care:
Length at 18 months was significantly greater in group receiving Enov’Nutributter®+ compared to control group and stunting prevalence was significantly lower in these groups (29.3%) than control group (39.3%)
Wasting prevalence was also significantly lower in the group receiving Enov’Nutributter®+ (8.7%) than control group (13.5%)
Significantly higher performance on motor, language, and personal-social development measures at 18 months compared to the control arm
 Adu-Afarwuah S et al. “Acceptability of lipid-based nutrient supplements (LNS) among Ghanaian infants and pregnant and lactating women.” (2011) Maternal and Child Nutrition.
 Hess et al. “Small-quantity Lipid-Based Nutrient supplements, regardless of their zinc content, increase growth and reduce the prevalence of stunting and wasting in young Burkinabe children: a cluster-randomized trial.” (2015)